These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 65996)

  • 1. [Active role of phosphodiesterases in regulation of cyclic AMP metabolism in the thyroid gland (proceedings)].
    Erneux C; Boeynaems JM; Van Sande J; Dumont JE
    Arch Int Physiol Biochim; 1976 Dec; 84(5):1070-2. PubMed ID: 65996
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclic nucleotides phosphodiesterases inhibitors].
    Hagiwara M; Hidaka H
    Nihon Rinsho; 1991 Sep; 49(9):1993-8. PubMed ID: 1660084
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate.
    Erneux C; Van Sande J; Dumont JE; Boeynaems JM
    Eur J Biochem; 1977 Jan; 72(1):137-47. PubMed ID: 12974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP.
    Goldberg ND; O'Dea RF; Haddox MK
    Adv Cyclic Nucleotide Res; 1973; 3():155-223. PubMed ID: 4150323
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens.
    Seftel AD
    J Urol; 2005 Sep; 174(3):1043. PubMed ID: 16094045
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
    Manganiello V
    Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
    [No Abstract]   [Full Text] [Related]  

  • 7. Rod outer segment phosphodiesterase: factors affecting the hydrolysis of cyclic-AMP and cyclic-GMP.
    Chader G; Fletcher R; Johnson M; Bensinger R
    Exp Eye Res; 1974 Jun; 18(6):509-15. PubMed ID: 4369151
    [No Abstract]   [Full Text] [Related]  

  • 8. Possibilities for drug development based on the cyclic AMP system.
    Amer MS; McKinney GR
    Life Sci; 1973 Oct; 13(7):753-67. PubMed ID: 4358272
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterase of human cerebrospinal fluid.
    Hidaka H; Shibuya M; Asano T; Hara F
    J Neurochem; 1975 Jul; 25(1):49-53. PubMed ID: 237062
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple molecular forms of phosphodiesterase: an overview.
    Weishaar RE
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):463-72. PubMed ID: 2831256
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormonal regulation of cyclic nucleotide phosphodiesterases.
    Conti M; Jin SL; Monaco L; Repaske DR; Swinnen JV
    Endocr Rev; 1991 Aug; 12(3):218-34. PubMed ID: 1657587
    [No Abstract]   [Full Text] [Related]  

  • 12. A mechanism in the control of intracellular cAMP level: the activation of a calmodulin-sensitive phosphodiesterase by a rise of intracellular free calcium.
    Erneux C; Van Sande J; Miot F; Cochaux P; Decoster C; Dumont JE
    Mol Cell Endocrinol; 1985 Dec; 43(2-3):123-34. PubMed ID: 3000848
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD; Bornfeldt KE
    Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclic nucleotides and phosphodiesterases in platelets.
    Haslam RJ; Dickinson NT; Jang EK
    Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic nucleotide metabolism in electroplax of Electrophorus electricus.
    Childers SR; Siegel FL
    J Neurochem; 1977 Jun; 28(6):1229-35. PubMed ID: 195014
    [No Abstract]   [Full Text] [Related]  

  • 16. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
    Gupta R; Kumar G; Kumar RS
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase genes and antidepressant treatment response: a review.
    Esposito K; Reierson GW; Luo HR; Wu GS; Licinio J; Wong ML
    Ann Med; 2009; 41(3):177-85. PubMed ID: 18932104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of divalent cations on regulation of cyclic GMP and cyclic AMP levels in brain tissue.
    Ferrendelli JA; Rubin EH; Kinscherf DA
    J Neurochem; 1976 Apr; 26(4):741-8. PubMed ID: 184244
    [No Abstract]   [Full Text] [Related]  

  • 19. Negative regulation of cyclic AMP levels by activation of cyclic nucleotide phosphodiesterases: the example of the dog thyroid.
    Dumont JE; Miot F; Erneux C; Couchie D; Cochaux P; Gervy-Decoster C; Van Sande J; Wells JN
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():325-36. PubMed ID: 6202125
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterases.
    Essayan DM
    J Allergy Clin Immunol; 2001 Nov; 108(5):671-80. PubMed ID: 11692087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.